For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| 1-Food Elimination Diet (1FED) | Participants eliminate milk from the diet in Phase 1 1 Food Elimination Diet Therapy | 0 | None | 0 | 67 | 1 | 67 | View |
| 6-Food Elimination Diet (6FED) | Participants eliminate milk, egg, wheat, soy, nuts, fish from the diet in Phase 1 6 Food Elimination Diet Therapy | 0 | None | 0 | 62 | 2 | 62 | View |
| 1FED Non-Responders (6FED) | Participants that fail to respond to 1FED in Phase 1 eliminate milk, egg, wheat, soy, nuts, fish from the diet in Phase 2 6 Food Elimination Diet (after 1FED failure) | 0 | None | 0 | 21 | 0 | 21 | View |
| 6FED Non-responders (SGC) | Participants that fail to respond to 6FED in Phase 1 administer swallowed glucocorticoids (SGC) (Flovent HFA) 880 mcg twice daily in Phase 2 Fluticasone Propionate, 880 mcg twice daily (after 6FED failure) | 0 | None | 1 | 11 | 4 | 11 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Suicidal ideation | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCAE (4.0) | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Gastrointestinal Pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE (4.0) | View |
| Diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE (4.0) | View |
| Bronchial Infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCAE (4.0) | View |
| Adrenal insufficiency | NON_SYSTEMATIC_ASSESSMENT | Endocrine disorders | CTCAE (4.0) | View |